Education
About Us
Working with TipRanks
Follow Us
AlzeCure Pharma AB (SE:ALZCUR)
:ALZCUR
RESEARCH TOOLSreports
ALZCUR Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.77 - kr4.95
Previous CloseN/A
Volume72.39K
Average Volume (3M)224.04K
Market Cap
€322.91M
Enterprise Valuekr234.65M
Total Cash (Recent Filing)€20.82M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta-0.38
Next Earnings
Nov 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding114,914,450
10 Day Avg. Volume221,418
30 Day Avg. Volume224,039
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ALZCUR FAQ
What was AlzeCure Pharma AB’s price range in the past 12 months?
AlzeCure Pharma AB lowest stock price was kr0.77 and its highest was kr4.95 in the past 12 months.
What is AlzeCure Pharma AB’s market cap?
AlzeCure Pharma AB’s market cap is €322.91M.
When is AlzeCure Pharma AB’s upcoming earnings report date?
AlzeCure Pharma AB’s upcoming earnings report date is Nov 11, 2025 which is in 53 days.
How were AlzeCure Pharma AB’s earnings last quarter?
AlzeCure Pharma AB released its earnings results on Aug 26, 2025. The company reported -kr0.105 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.105.
Is AlzeCure Pharma AB overvalued?
According to Wall Street analysts AlzeCure Pharma AB’s price is currently Overvalued.
Does AlzeCure Pharma AB pay dividends?
AlzeCure Pharma AB does not currently pay dividends.
What is AlzeCure Pharma AB’s EPS estimate?
AlzeCure Pharma AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AlzeCure Pharma AB have?
AlzeCure Pharma AB has 114,914,450 shares outstanding.
What happened to AlzeCure Pharma AB’s price movement after its last earnings report?
AlzeCure Pharma AB reported an EPS of -kr0.105 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9%.
Which hedge fund is a major shareholder of AlzeCure Pharma AB?
Currently, no hedge funds are holding shares in SE:ALZCUR
Company Description
AlzeCure Pharma AB
AlzeCure Pharma AB (ALZCUR) is a Swedish pharmaceutical company that focuses on developing innovative therapies for neurodegenerative diseases, with a particular emphasis on Alzheimer's disease and pain management. The company operates in the biotechnology sector, leveraging its expertise in neuroscience to advance its pipeline of drug candidates. AlzeCure's core products include a range of proprietary small molecule drugs that target key pathways involved in neurodegeneration.
Technical Analysis
Orexo AB
―
Klaria Pharma Holding AB
―
Nanexa AB
―
Enzymatica AB
―
Enorama Pharma AB
―